Thermo Scientific Orbitrap Astral Mass Spectrometer
- Institution
- MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC
- Principal investigator
- Lauren Elizabeth Ball
- Funding
- $1.7M
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY This proposal is requesting funds to acquire a Thermo Scientific Orbitrap Astral Mass Spectrometer for the Mass Spectrometry Facility & Proteomics Center at the Medical University of South Carolina in Charleston, South Carolina. This instrument will support NIH-funded research in areas of cancer, immunotherapy, cardiovascular disease, liver and digestive disease, neurological disease, and addiction. Acquisition of this equipment will provide state-of-the-art research capabilities for our investigators and meet the growing demand for ultra- sensitive quantitative proteomic experiments for limited sample amounts and post-translational modifications of low abundance. This high resolution and accurate mass instrument with Quadrupole, Orbitrap, and Astral mass analyzers exhibits 4-5x faster data acquisition rates than our current instruments improving the sensitivity, quantitative resolution, and reproducibility of measurements. This new advance in technology will speed the discovery of mechanisms underlying disease onset and progression and yield insights into the response to therapeutics. The requested instrumentation is to be housed in the Mass Spectrometry Facility, a University Shared Research Resource Facility, to provide LC-MS/MS based proteomic capabilities to investigators at the Medical University of South Carolina and academic institutions in South Carolina.
LOADING MOONBASE SCORE
Questions for MEDICAL UNIVERSITY OF SOUTH CAROLINA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Medical University of South CarolinaNot yet scored
Proteomics Core
Lauren Elizabeth Ball · $272K · 2021–2026
- NIH · Medical University of South Carolina67
Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit
Jennifer Renee Dahne · $924K · 2022–2028
- NIH · Medical University of South Carolina48
Reversing inflammatory macrophage activation as treatment for neonatal intraventricular hemorrhage and hydrocephalus
Brandon A Miller · $175K · 2024–2025